Search

Author/Creator Jouffroy, Thomas

1. Ligand–receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma. (2nd July 2016)

Authors:
Guillot-Delost, Maude; Guilleré, Lia; Berger, Frédérique; Ventre, Aurore; Michea, Paula; Sirven, Philémon; Pattarini, Lucia; Scholer-Dahirel, Alix; Kebir, Fatima-Zahra; Huerre, Michel; Chouchane-Mlik, Olfa; Lappartient, Emmanuelle; Rodriguez, José; Jouffroy, Thomas; Klijanienko, Jerzy; Nicolas, A...
Journal:
Oncoimmunology
Issue:
Volume 5:Number 7(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study. (July 2021)

Authors:
Tourneau, Christophe Le; Calugaru, Valentin; Moreno, Victor; Calvo, Emiliano; Liem, Xavier; Salas, Sébastien; Doger, Bernard; Jouffroy, Thomas; Mirabel, Xavier; Rodriguez, Jose; Chilles, Anne; Bernois, Katell; Fakhry, Nicolas; Kam, Stéphanie Wong Hee; Hoffmann, Caroline
Journal:
Oral oncology
Issue:
Volume 118(2021)Supplement
Page Start:
11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗